Loch N, Tauber R, Becker A, Hartel-Schenk S, Reutter W
Institut für Molekularbiologie und Biochemie, Freie Universität Berlin, Federal Republic of Germany.
Eur J Biochem. 1992 Nov 15;210(1):161-8. doi: 10.1111/j.1432-1033.1992.tb17404.x.
N-Glycosylation, biosynthesis and degradation of dipeptidylpeptidase IV (EC 3.4.14.5) (DPP IV) were comparatively studied in primary cultured rat hepatocytes and Morris hepatoma 7777 cells (MH 7777 cells). DPP IV had a molecular mass of 105 kDa in rat hepatocytes and of 103 kDa in MH 7777 cells as assessed by SDS/PAGE under reducing conditions. This difference in molecular mass was caused by differences in covalently attached N-glycans. DPP IV from hepatoma cells contained a higher proportion of N-glycans of the oligomannosidic or hybrid type and therefore migrated at a slightly lower molecular mass. In both cell types DPP IV was initially synthesized as a 97-kDa precursor which was completely susceptible to digestion with endo-beta-N-acetylglucosaminidase H converting the molecular mass to 84 kDa. The precursor was processed to the mature forms of DPP IV, glycosylated with N-glycans mainly of the complex type with a half-life of 20-25 min. The transit of newly synthesized DPP IV to the cell surface displayed identical or very similar kinetics in both cell types with the major portion of DPP IV appearing at the cell surface after 60 min. DPP IV molecules were very slowly degraded in hepatocytes as well as in hepatoma cells with half-lives of approximately 45 h. Inhibition of oligosaccharide processing with 1-deoxymannojirimycin led to the formation of DPP IV molecules containing N-glycans of the oligomannosidic type. This glycosylation variant was degraded with the same half-life as complex-type glycosylated DPP IV. By contrast, inhibition of N-glycosylation with tunicamycin resulted into rapid degradation of non-N-glycosylated DPP IV molecules in both cell types. Non-N-glycosylated DPP IV could not be detected at the cell surface indicating an intracellular proteolytic process soon after biosynthesis.
在原代培养的大鼠肝细胞和莫里斯肝癌7777细胞(MH 7777细胞)中,对二肽基肽酶IV(EC 3.4.14.5)(DPP IV)的N-糖基化、生物合成及降解过程进行了比较研究。在还原条件下通过SDS/PAGE评估,DPP IV在大鼠肝细胞中的分子量为105 kDa,在MH 7777细胞中的分子量为103 kDa。分子量的这种差异是由共价连接的N-聚糖的差异引起的。肝癌细胞中的DPP IV含有较高比例的低聚甘露糖型或杂合型N-聚糖,因此迁移时分子量略低。在两种细胞类型中,DPP IV最初均作为97 kDa的前体合成,该前体完全易被内切β-N-乙酰氨基葡萄糖苷酶H消化,分子量转变为84 kDa。前体被加工成DPP IV的成熟形式,主要被复杂型N-聚糖糖基化,半衰期为20 - 25分钟。新合成的DPP IV转运至细胞表面在两种细胞类型中表现出相同或非常相似的动力学,60分钟后大部分DPP IV出现在细胞表面。DPP IV分子在肝细胞和肝癌细胞中的降解都非常缓慢,半衰期约为45小时。用1-脱氧甘露基野尻霉素抑制寡糖加工导致形成含有低聚甘露糖型N-聚糖的DPP IV分子。这种糖基化变体的降解半衰期与复杂型糖基化的DPP IV相同。相比之下,用衣霉素抑制N-糖基化导致两种细胞类型中非N-糖基化的DPP IV分子快速降解。在细胞表面未检测到非N-糖基化的DPP IV,表明生物合成后不久存在细胞内蛋白水解过程。